The transcription factor RIP140 regulates interferon γ signaling in breast cancer
Stéphan Jalaguier, Axel Kuehn, Chloé Petitpas, Arnaud Dulom, Rémy Jacquemont, Cindy Assi, Sophie F. Doisneau-Sixou, Udo Jeschke, Jacques Colinge, Vincent Cavaillès
This study identifies RIP140 as a regulator of IFNγ signaling in breast cancer, showing its repression of IFNγ-induced GBP1 expression and its role in enhancing IFNγ's anti-tumor effects.
International Journal of Cancer · Mar 10, 2025Peer-reviewedCancer Biology